DOCSLIB.ORG

Diagnostic Tests for Vaginosis/Vaginitis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnostic Tests for Vaginosis/Vaginitis Alberta Heritage Foundation for Medical Research Diagnostic tests for vaginosis/vaginitis Christa Harstall and Paula Corabian October 1998 HTA12 Diagnostic tests for vaginosis/vaginitis Christa Harstall and Paula Corabian October 1998 © Copyight Alberta Heritage Foundation for Medical Research, 1998 This Health Technology Assessment Report has been prepared on the basis of available information of which the Foundation is aware from public literature and expert opinion, and attempts to be current to the date of publication. The report has been externally reviewed. Additional information and comments relative to the Report are welcome, and should be sent to: Director, Health Technology Assessment Alberta Heritage Foundation for Medical Research 3125 Manulife Place, 10180 - 101 Street Edmonton Alberta T5J 3S4 CANADA Tel: 403-423-5727, Fax: 403-429-3509 This study is based, in part, on data provided by Alberta Health. The interpretation of the data in the report is that of the authors and does not necessarily represent the views of the Government of Alberta. ISBN 1-896956-15-7 Alberta's health technology assessment program has been established under the Health Research Collaboration Agreement between the Alberta Heritage Foundation for Medical Research and the Alberta Health Ministry. Acknowledgements The Alberta Heritage Foundation for Medical Research is most grateful to the following persons for their comments on the draft report and for provision of information. The views expressed in the final report are those of the Foundation. Dr. Jane Ballantine, Section of General Practice, Calgary Dr. Deirdre L. Church, Microbiology, Calgary Laboratory Services, Calgary Dr. Nestor N. Demianczuk, Royal Alexandra Hospital, Edmonton Dr. Maire A. Duggan, Calgary Laboratory Services, Calgary Dr. Patrick Gibb, Microbiology, Calgary Laboratory Services, Calgary Dr. Devidas Menon, Institute of Pharmaco-Economics, Edmonton Dr. Miriam Orleans, University of Colorado, Denver Dr. Robert P. Rennie, University of Alberta Hospital, Edmonton Dr. S. Nanette Schuurmans, Women’s Health Program, Edmonton Dr. Jack D. Sorbel, Harper Hospital, Detroit Contents Summary ........................................................................................................................................ 1 Introduction ................................................................................................................................... 2 Diagnostic tests .............................................................................................................................. 3 Practice patterns in Alberta ......................................................................................................... 3 Bacterial vaginosis ........................................................................................................................ 4 Candidiasis .................................................................................................................................... 6 Trichomoniasis .............................................................................................................................. 8 Studies of accuracy ....................................................................................................................... 9 Conclusions .................................................................................................................................. 11 References .................................................................................................................................... 29 Tables of publications on diagnosis of vaginosis/vaginitis Abbreviations .............................................................................................................................. 13 Table 1: Studies of accuracy for diagnosis of vaginitis/vaginosis ............................... 14 Table 2: Reviews on diagnosis of vaginitis/vaginosis ................................................... 21 Appendix A: Methodology ..................................................................................................... 23 Appendix B: Alberta Health Care Insurance Plan Physician Payment Administrative Database ................................................................ 26 Prevalence data Table 3: Estimated age adjusted physician contact prevalence, 1996/97 .................... 27 Table 4: Estimated age adjusted physician contact prevalence, 1997/98 .................... 27 Table 5: Prevalence rate for the total population ............................................................ 27 Data on costs and specialities Table 6: Physician payments, 1996/97 and 1997/98 ...................................................... 28 Table 7: Services provided by speciality .......................................................................... 28 Summary The importance of accurate, reproducible and rapid laboratory methods to diagnose the cause of vaginitis symptoms has increased as recent data suggest an association between bacterial vaginosis, candidiasis and trichomoniasis, and obstetrical and gynecological complications. These are diagnostically complex diseases and in some incidences more than one disease state may be present. Currently, the diagnosis of the cause of vaginitis symptoms requires both the assessment of clinical symptoms (vaginal discharge, odour, appearance, discomfort) and the performance of diagnostic tests (pH, microscopic evaluation, whiff test, occasionally cultures). There is a need for scientific evidence to establish a causal relation or association of bacterial vaginitis, candidiasis and trichomoniasis with such serious gynecological and obstetrical conditions as late onset miscarriage, preterm birth, postabortal pelvic inflammatory disease, post caesarian section endometritis and HIV. Without this information, it is difficult to set the acceptable limits of sensitivity and specificity for diagnostic tests. The primary studies of accuracy included in this assessment are of fairly poor methodological quality and design. Moreover, the scientific evidence to date suggests relatively poor diagnostic performance. The accuracy of the clinical criteria used for the diagnosis of these three disease states also needs to be re-evaluated. Most of the published studies located are from researchers in the United States and other countries. Guidelines based on existing evidence should take into account that the results from these studies are not generalizable to the situation in Alberta since the practice patterns seem to be very different. For the fiscal year 1997/98 in Alberta, 16,473 women of childbearing age had a confirmed diagnosis of either one or a combination of bacterial vaginosis, candidiasis and trichomoniasis. Females between the ages of 21 to 25 years are the population at highest risk. There seem to be some promising tests on the horizon but these are expensive techniques requiring specialized skills. Antibody and DNA based techniques have the potential to increase accuracy and decrease the time taken for laboratory identification. Further work is needed on their cost effectiveness in routine application. 1 Introduction This report has been prepared following a request from the provincial Clinical Practice Guidelines Program for information on the accuracy of diagnostic tests for the detection of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis in females of reproductive age. The intention of this document is to provide background and scientific evidence for the potential development of a provincial guideline. The focus of the report is the diagnosis of vaginitis, an inflammation of the vagina, and vaginosis, an imbalance in the normal flora of the vagina without inflammation. Specifically, this assessment looks at the analytical performance (sensitivity, specificity, positive and negative predictive values) of the current or new diagnostic tests for BV, VVC and trichomoniasis. The methodology used for the literature review is outlined in Appendix A. Vaginal infections are frequently the cause of distress and discomfort in adult women. The American College of Obstetricians and Gynecologists and others have noted that symptoms of vaginitis are the most common gynecologic problem seen by obstetricians/gynecologists and physicians providing primary care (19,30,49) . Vaginal discharge was listed among the top 25 reasons for physician consultation (19). The vaginal ecosystem is a complex biosphere composed of a great variety of microorganisms; these interact in various ways to maintain a balanced or healthy state. The ecosystem is in a constant state of flux and its equilibrium is constantly challenged by both endogenous and exogenous factors (16) . Factors that may alter the delicate equilibrium are the following: antibiotics, hormones, contraceptive preparations (oral and topical), douches, sexual intercourse, presence of foreign bodies such as IUDs, alterations in immune status, sexually transmitted diseases, stress and change in partners (21,49) . The concept of an unbalanced versus a diseased vaginal ecosystem needs be understood by both the patient and the physician. Diseases of the vagina which may cause an abnormal vaginal discharge may fall into one of three categories: infectious, allergic and neoplastic; whereas an unbalanced ecosystem, referred to as vaginosis, reflects a disturbance which has caused an alteration in the vaginal microflora (16) . It is common for the terms vaginitis and vaginosis to
Load more

Recommended publications
  • Developmental Abnormalities Easy to Misdiagnose
    8 Gynecology O B .GYN. NEWS • March 15, 2005 Developmental Abnormalities Easy to Misdiagnose BY JANE SALODOF MACNEIL inappropriate surgery, according to Dr. even an entity called obstructed hemi- Abnormalities of the vulva include con- Contributing Writer Zurawin, chief of the section of pediatric vagina.” genital labial fusion, which he said could and adolescent gynecology at Baylor and Clitoral hypertrophy is the only devel- be corrected with a simple flap proce- H OUSTON — Developmental abnor- of the gynecology service at Texas Chil- opmental abnormality of the clitoris, ac- dure. Surgery is rarely used, however, for malities of the vulva and vagina are often dren’s Hospital in Houston. cording to Dr. Zurawin. It used to be acquired labial agglutination. “This is one easy to correct, but also easy to misdiag- “You need to be familiar with the syn- treated by clitoridectomy with “very un- of most common referrals from pediatri- nose, Robert K. Zurawin, M.D., warned at dromes before you treat. Many people satisfactory results,” he said, describing cians, because they don’t know what to do a conference on vulvovaginal diseases are confronted with these conditions, and more conservative procedures in use to- with it and they are afraid,” Dr. Zurawin sponsored by Baylor College of Medicine. they don’t know what they really are,” he day. “This is mainly a cosmetic problem said. Many physicians have not been trained said. “With the obstructions, for example, for patients, and the surgical management He attributed most cases to diaper rash, to recognize these rare disorders and, as a they may just think it is an imperforate hy- is resection of the enlarged clitoris,” he bubble baths, and detergents that can in- result, run the risk of doing excessive or men and are not even aware that there is said.
    [Show full text]
  • ICD10 Diagnoses FY2018 AHD.Com
    ICD10 Diagnoses FY2018 AHD.com A020 Salmonella enteritis A5217 General paresis B372 Candidiasis of skin and nail A040 Enteropathogenic Escherichia coli A523 Neurosyphilis, unspecified B373 Candidiasis of vulva and vagina infection A528 Late syphilis, latent B3741 Candidal cystitis and urethritis A044 Other intestinal Escherichia coli A530 Latent syphilis, unspecified as early or B3749 Other urogenital candidiasis infections late B376 Candidal endocarditis A045 Campylobacter enteritis A539 Syphilis, unspecified B377 Candidal sepsis A046 Enteritis due to Yersinia enterocolitica A599 Trichomoniasis, unspecified B3781 Candidal esophagitis A047 Enterocolitis due to Clostridium difficile A6000 Herpesviral infection of urogenital B3789 Other sites of candidiasis A048 Other specified bacterial intestinal system, unspecified B379 Candidiasis, unspecified infections A6002 Herpesviral infection of other male B380 Acute pulmonary coccidioidomycosis A049 Bacterial intestinal infection, genital organs B381 Chronic pulmonary coccidioidomycosis unspecified A630 Anogenital (venereal) warts B382 Pulmonary coccidioidomycosis, A059 Bacterial foodborne intoxication, A6920 Lyme disease, unspecified unspecified unspecified A7740 Ehrlichiosis, unspecified B387 Disseminated coccidioidomycosis A080 Rotaviral enteritis A7749 Other ehrlichiosis B389 Coccidioidomycosis, unspecified A0811 Acute gastroenteropathy due to A879 Viral meningitis, unspecified B399 Histoplasmosis, unspecified Norwalk agent A938 Other specified arthropod-borne viral B440 Invasive pulmonary
    [Show full text]
  • 2021 – the Following CPT Codes Are Approved for Billing Through Women’S Way
    WHAT’S COVERED – 2021 Women’s Way CPT Code Medicare Part B Rate List Effective January 1, 2021 For questions, call the Women’s Way State Office 800-280-5512 or 701-328-2389 • CPT codes that are specifically not covered are 77061, 77062 and 87623 • Reimbursement for treatment services is not allowed. (See note on page 8). • CPT code 99201 has been removed from What’s Covered List • New CPT codes are in bold font. 2021 – The following CPT codes are approved for billing through Women’s Way. Description of Services CPT $ Rate Office Visits New patient; medically appropriate history/exam; straightforward decision making; 15-29 minutes 99202 72.19 New patient; medically appropriate history/exam; low level decision making; 30-44 minutes 99203 110.77 New patient; medically appropriate history/exam; moderate level decision making; 45-59 minutes 99204 165.36 New patient; medically appropriate history/exam; high level decision making; 60-74 minutes. 99205 218.21 Established patient; evaluation and management, may not require presence of physician; 99211 22.83 presenting problems are minimal Established patient; medically appropriate history/exam, straightforward decision making; 10-19 99212 55.88 minutes Established patient; medically appropriate history/exam, low level decision making; 20-29 minutes 99213 90.48 Established patient; medically appropriate history/exam, moderate level decision making; 30-39 99214 128.42 minutes Established patient; comprehensive history exam, high complex decision making; 40-54 minutes 99215 128.42 Initial comprehensive
    [Show full text]
  • Womens Health Requisition Forms
    PCR - WHI Implementation PLACE ON SWAB 10854 Midwest Industrial Blvd. St. Louis, MO 63132 MM DD YY Phone: (314) 200-3040 | Fax (314) 200-3042 (1) CLIA ID #26D0953866 JANE DOE v3 PCR MOLECULAR REQUISITION - WOMEN'S HEALTH INFECTION PRACTICE INFORMATION PATIENT INFORMATION *SPECIMEN INFORMATION (2) DOE JANE MM/DD/YY LAST NAME FIRST NAME DATE COLLECTED W O M E ' N S H E A L T H I F N E C T I O N SSN MM/DD/YY HH:MM AM SSN DATE OF BIRTH TIME COLLECTED REQUESTING PHYSICIAN: DR. SWAB TESTER (3) Sex: F X M (4) Diagnosis Codes X N76.0 Acute vaginitis B37.49 Other urogenital candidiasis A54.9 Gonococcal infection, unspecified N76.1 Subacute and chronic vaginitis N89.8 Other specified noninflammatory disorders of vagina A59.00 Urogenital trichomoniasis, unspecified N76.2 Acute vulvitis O99.820 Streptococcus B carrier state complicating pregnancy A64 Unspecified sexually transmitted disease N76.3 Subacute and chronic vulvitis O99.824 Streptococcus B carrier state complicating childbirth A74.9 Chlamydial infection, unspecified N76.4 Abscess of vulva B95.1 Streptococcus, group B, as the cause Z11.3 Screening for infections with a predmoninantly N76.5 Ulceration of vagina of diseases classified elsewhere sexual mode of trasmission N76.6 Ulceration of vulva Z22.330 Carrier of group B streptococcus Other: N76.81 Mucositis(ulcerative) of vagina and vulva N70.91 Salpingitis, unspecified N76.89 Other specified inflammation of vagina and vulva N70.92 Oophoritis, unspecified N95.2 Post menopausal atrophic vaginitis N71.9 Inflammatory disease of uterus, unspecified
    [Show full text]
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • Colposcopy.Pdf
    CCololppooscoscoppyy ► Chris DeSimone, M.D. ► Gynecologic Oncology ► Images from Colposcopy Cervical Pathology, 3rd Ed., 1998 HistoHistorryy ► ColColpposcopyoscopy wwasas ppiioneeredoneered inin GGeermrmaanyny bbyy DrDr.. HinselmannHinselmann dduriurinngg tthhee 19201920’s’s ► HeHe sousougghtht ttoo prprooveve ththaatt micmicrroscopicoscopic eexaminxaminaationtion ofof thethe cervixcervix wouwoulldd detectdetect cervicalcervical ccancanceerr eeararlliierer tthhaann 44 ccmm ► HisHis workwork identidentiifiefiedd severalseveral atatyypicalpical appeappeararanancceses whwhicichh araree stistillll usedused ttooddaay:y: . Luekoplakia . Punctation . Felderung (mosaicism) Colposcopy Cervical Pathology 3rd Ed. 1998 HistoHistorryy ► ThrThrooughugh thethe 3030’s’s aanndd 4040’s’s brbreaeaktkthrhrouougghshs wwereere mamaddee regregaarrddinging whwhicichh aapppepeararancanceess wweerere moremore liklikelelyy toto prprogogressress toto invinvaasivesive ccaarcinomrcinomaa;; HHOOWEWEVVERER,, ► TheThessee ffiinndingsdings wweerere didifffficiculultt toto inteinterrpretpret sincesince theythey werweree notnot corcorrrelatedelated wwithith histologhistologyy ► OneOne resreseaearcrchherer wwouldould claclaiimm hhiiss ppatatientsients wwithith XX ffindindiingsngs nevernever hahadd ccaarcinomarcinoma whwhililee aannothotheerr emphemphaatiticcallyally belibelieevedved itit diddid ► WorldWorld wiwidede colposcopycolposcopy waswas uunnderderuutitillizizeedd asas aa diadiaggnosticnostic tooltool sseeconcondadaryry ttoo tthheseese discrepadiscrepannciescies HistoHistorryy
    [Show full text]
  • Key Points: • a Pap Test and Pelvic Exam Are Important Parts of A
    Key Points: • A Pap test and pelvic exam are important parts of a woman’s routine health care because they can detect cancer or abnormalities that may lead to cancer of the cervix (see Question 3). • Women should have a Pap test at least once every three years, beginning about three years after they begin to have sexual intercourse, but no later than age 21 (see Question 6). • If the Pap test shows abnormalities, further tests an/or treatment may be necessary (see Question 11). • Human papillomavirus (HPV) infection is the primary risk factor for cervical cancer (see Question 13). 1. What is a Pap test? The Pap test (sometimes called a Pap smear) is a way to examine cells collected from the cervix (the lower, narrow end of the uterus). The main purpose of the Pap test is to find abnormal cell changes that may arise from cervical cancer or before cancer develops. 2. What is a pelvic exam? In a pelvic exam, the uterus, vagina, ovaries, fallopian tubes, bladder, and rectum are felt to find any abnormality in their shape or size. During a pelvic exam, an instrument called a speculum is used to widen the vagina so that the upper portion of the vagina and the cervix can be seen. 3. Why are a Pap test and pelvic exam important? A Pap test and pelvic exam are important parts of a woman’s routine health care because they can detect abnormalities that may lead to invasive cancer of the cervix. These abnormalities can be treated before cancer develops.
    [Show full text]
  • The Relationship Between Female Genital Aesthetic Perceptions and Gynecological Care
    Examining the Vulva: The Relationship between Female Genital Aesthetic Perceptions and Gynecological Care By Vanessa R. Schick B.A. May 2004, University of Massachusetts, Amherst A Dissertation Submitted to The Faculty of Columbian College of Arts and Sciences of The George Washington University in Partial Satisfaction of the Requirements for the Degree of Doctor of Philosophy January 31, 2010 Dissertation directed by Alyssa N. Zucker Associate Professor of Psychology and Women’s Studies The Columbian College of Arts and Sciences of The George Washington University certifies that Vanessa R. Schick has passed the Final Examination for the degree of Doctor of Philosophy as of August 19, 2009. This is the final and approved form of the dissertation. Examining the Vulva: The Relationship between Female Genital Aesthetic Perceptions and Gynecological Care Vanessa R. Schick Dissertation Research Committee: Alyssa N. Zucker, Associate Professor of Psychology & Women's Studies, Dissertation Director Laina Bay-Cheng, Assistant Professor of Social Work, University at Buffalo, Committee Member Maria-Cecilia Zea, Professor of Psychology, Committee Member ii © Copyright 2009 by Vanessa R. Schick All rights reserved iii Acknowledgments The past five years have changed me and my research path in ways that I could have never imagined. I feel incredibly fortunate for my mentors, colleagues, friends and family who have supported me throughout this journey. First, I would like to start by expressing my sincere appreciation to my phenomenal dissertation committee and all those who made this dissertation possible: Without Alyssa Zucker, my advisor, my journey would have been an entirely different one. Few advisors would allow their students to forge their own research path.
    [Show full text]
  • Laboratory Test: Wet Prep Standing Order in N.C
    Laboratory Test: Wet Prep Standing Order in N.C. Board of Nursing Format INSTRUCTIONS FOR LOCAL HEALTH DEPARTMENT STAFF ONLY Use the approved language in this standing order to create a customized standing order exclusively for your agency. Print the customized standing order on agency letterhead. Review standing order at least annually and obtain Medical Director’s signature. Standing order must include the effective start date and the expiration date. Assessment Subjective Findings The following subjective criteria meet the requirement for an STD ERRN to collect a Wet Prep by standing order: Vaginal discharge with or without foul odor Dyspareunia Dysuria New or multiple sex partner(s) Lack of condom use Reports contact to: Chlamydia (CT), Gonorrhea Asymptomatic (GC), Non-Gonococcal Urethritis (NGU), Pelvic Anonymous sex Inflammatory Disease (PID), Mucopurulent Cervicitis (MPC), or Trichomonas vaginalis (TV) Objective Findings If one or more of these clinical findings are present, the STD ERRN shall collect a Wet Prep by standing order: 1. vaginal discharge 2. endocervical discharge 3. foul odor 4. cervical inflammation, usually manifest as edema or easily induced cervical bleeding upon cervical swabbing 5. petechiae on cervix 6. vaginal or vulva irritation 7. warts or other abnormal growths in vagina or on cervix 8. vaginal exposure within last 60 days 9. verified contact Gonorrhea, Chlamydia, NGU, MPC or Trichomonas Plan of Care Implementation A registered nurse or STD ERRN employed or contracted by the local health department may order a Wet Prep collected by the STD ERRN or other medical provider. Nursing Actions A. Specimen Collection by STD ERRN: To collect a Wet Prep specimen: 1.
    [Show full text]
  • Remarks on Pelvic Peritonitis and Pelvic Cellulitis, with Illustrative Cases
    Article IV.- Remarks on Pelvic Peritonitis and Pelvic Cellulitis, with Illustrative Cases. By Lauchlan Aitken, M.D. Rather moie than a year ago there appeared from the pen of a well- known of this a gynecologist city very able monograph on the two forms of pelvic inflammation whose names head this article; and it cannot have escaped the recollection of the reader that Dr M. Dun- can, adopting the nomenclature first proposed by Yirchow, has used on his different terms title-page1 than those older appellations I still to retain. Under these propose ^ circumstances I feel at to compelled least to attempt justify my preference for the original names: and I trust to be able to show that are they preferable to, and less con- others that fusing than, any have as yet been proposed, even though we cannot consider them absolutely perfect. 1 Treatise on A Practical Perimetritis and Parametritis (Edin. 1869). 1870.] DR LAUCI1LAN AITKEN ON PELVIC FERITONITIS, ETC. 889 Passing over, then, such terms as 'periuterine cellulitis or phleg- mons periuterins as bad compounds ; others, as inflammation of the broad ligaments, as too limited in meaning ; and others, again, as engorgement periutdrin, as only indicating one of the stages of the affection,?I shall endeavour as succinctly as possible to state my reasons for preferring the older names to those proposed by Virchow. ls?. The two Greek prepositions, peri and para, are employed somewhat arbitrarily to indicate inflammatory processes which are essentially distinct. I say arbitrarily, because I am not aware that para has been generally employed in the form of a compound to ex- press inflammation of the cellular tissue elsewhere.1 By those who remember that the cellular tissue not only separates the serous membrane from the uterus at that part where the cervix and body of the organ meet, but is even abundant there,2 perimetritis might readily be taken to indicate one of the varieties, though indeed not a in for which very common one, of pelvic cellulitis?a variety, fact, the term perimetric cellulitis has been proposed.
    [Show full text]
  • Advanced-Pelvic-Exams1.Pdf
    8/3/2014 Describe at least two techniques for performing pelvic examination with a patient who has Jacki Witt, JD, MSN, WHNP-BC, SANE-A, FAANP experienced sexual assault/abuse Caroline Hewitt, DNS, RN, NP Practice at least two new pelvic examination techniques with a standardized patient Select appropriate screening and diagnostic testing for women with specific pelvic organ symptoms Jacki Witt Watson Pharmaceuticals – Honorarium – Advisory Board Agile Pharmaceuticals – Honorarium – Advisory WHO Afaxus Pharmaceuticals – Honorarium – Advisory Committee Bayer Pharmaceuticals – Honorarium – Advisory Board WHAT WHEN Caroline Hewitt WHERE Prior to February 5, 2014 disclosures: Watson Pharmaceuticals – Honorarium-Advisory Board HOW After February 5, 2014: Nothing to disclose WHY Identify the indications for a pelvic examination -Lithotomy common in US Describe at least two techniques for performing -Some patients pelvic examination with an obese patient find it disempowering, Describe at least two techniques for performing abusive & humiliating pelvic examination with a patient who has Haar, et al 1997 signs/symptoms of decreased estrogen stimulation -Patient’s have to vaginal tissues described metal Describe at least two techniques for performing stirrups as ‘cold’ pelvic examination with a & ‘hard’; say their use developmentally/cognitively disabled person is impersonal, sterile or degrading Olson 1981 1 8/3/2014 • 197 adult women having routine cervical cytology • Patients reported less discomfort and feelings of vulnerability if: PLASTIC : direct lamp connection, • Semi-reclining vs. supine transparency facilitates visualization, • No stirrup method used audible and sensible clicks distressing and • No significant differences in quality of cyto specimen considered not ‘green’ (but study not powered to definitively look at this outcome) • Routine in UK, Australia, N.
    [Show full text]
  • The Relative Risk
    Clinical Expert Series Pelvic Inflammatory Disease David E. Soper, MD Obstet Gynecol 2010;116(2) ACCME Accreditation The American College of Obstetricians and Gynecologists (ACOG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. (Continuing medical education credit for “Pelvic Inflammatory Disease” will be available through August 2013.) AMA PRA Category 1 CreditTM and ACOG Cognate Credit The American College of Obstetricians and Gynecologists (ACOG) designates this educational activity for a maximum of 2 AMA PRA Category 1 CreditsTM or up to a maximum of 2 Category 1 ACOG cognate credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Statement Current guidelines state that continuing medical education (CME) providers must ensure that CME activities are free from the control of any commercial interest. All authors, reviewers, and contributors have disclosed to the College all relevant financial relationships with any commercial interests. The authors, reviewers, and contributors declare that neither they nor any business associate nor any member of their immediate families has financial interest or other relationships with any manufacturer of products or any providers of services discussed in this program. Any conflicts have been resolved through group and outside review of all content. Before submitting this form, please print a completed copy as confirmation of your program participation. ACOG Fellows: To obtain credits, complete and return this form by clicking on “Submit” at the bottom of the page. Credit will be automatically recorded upon receipt and online transcripts will be updated twice monthly.
    [Show full text]